Navigation Links
CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Date:4/26/2012

competing products into the market.  CryoLife has also inherited certain risks and uncertainties related to its 2011 acquisition of Cardiogenesis' business.  These risks and uncertainties include that CryoLife's ability to maintain revenues and achieve growth in revenues from Cardiogenesis' revascularization technology in the future is dependent upon physician awareness of this technology as a safe, efficacious, and appropriate treatment for their patients, we will continue to purchase some of Cardiogenesis' key product components from single suppliers, and the loss of these suppliers could prevent or delay shipments of its products, delay clinical trials, or otherwise adversely affect our business, if Cardiogenesis' independent contract manufacturers fail to timely deliver sufficient quantities of some of Cardiogenesis' products and components, our Cardiogenesis operations may be harmed, Cardiogenesis' contract manufacturers are at locations that may be at risk from earthquakes or other natural disasters, Cardiogenesis may have liability for actions that occurred prior to our acquisition of Cardiogenesis which could adversely affect us, and Cardiogenesis' internal controls over financial reporting may not have been effective prior to the merger, which could impact the value of our investment in Cardiogenesis and potentially lead to lawsuits from former Cardiogenesis shareholders, which could have a significant and adverse effect on CryoLife.  Cardiogenesis has been named as a defendant in a patent infringement lawsuit, and costly litigation may be necessary to protect or defend its intellectual property rights and an adverse judgment in this litigation could materially adversely impact our financial position, profitability or cash flows.  These risks and uncertainties related to Cardiogenesis' business that CryoLife has inherited also include the risk factors detailed in Cardiogenesis' Securities and Exchange Commission filings, including its Fo
'/>"/>
SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
2. CryoLife Enhances Management Team with Promotions
3. CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
4. CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
5. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial Results
8. CryoLife Provides Update on ValveXchange®, Inc. Investment
9. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
10. CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results
11. CryoLife Makes Equity Investment in ValveXchange® Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 ... the "Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, ... and Reagents], Application (Immunology, Oncology) & by ... published by MarketsandMarkets, provides a detailed overview ... current market trends, and strategies impacting the ...
(Date:9/30/2014)... Sept. 30, 2014 The Chinese wound care ... and rise in the incidence of lifestyle diseases, coupled ... in affordability of better quality of wound care products ... Universal coverage of public health insurance schemes and increased ... demand. Based on the findings of primary and secondary ...
(Date:9/30/2014)... 30, 2014 BioStructures, LLC has been ... of Tissue Banks (AATB), it was announced today ... Accreditation follows an intensive nine-month process, ... AATB inspector.  It establishes that the level of ... meets or exceeds the standards set by the ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4China Wound Care Market 2China Wound Care Market 3Biostructures, LLC Earns AATB Accreditation 2
... HAYWARD, Calif., Oct. 26 Anthera Pharmaceuticals, Inc. (Nasdaq: ... to treat serious diseases associated with inflammation, today announced ... after market close on Tuesday, November 2, 2010.  Anthera ... Time in conjunction with the release.Conference Call Access:Date: , ...
... Oct. 26 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... discovering breakthrough treatments for human disease, announced today that ... on Friday, November 5, 2010 before the financial markets ... discuss its clinical development progress and financial results for ...
Cached Medicine Technology:Anthera Announces Third Quarter 2010 Financial Report and Conference Call 2Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results 2
(Date:9/30/2014)... 2014 Integrated Medicine Alliance , ... another new medical specialty practice through a unique partnership ... will be located within the company’s Shrewsbury location and ... Isaac Tawfik of American Heart Center, P.C., a highly ... will offer Integrated Medicine Alliance patients top notch cardiovascular ...
(Date:9/30/2014)... University of Maryland-led research team has been awarded ... Institutes of Health (NIH) to develop new imaging ... our understanding of how large networks of neurons ... This knowledge will help researchers identify the precise ... behavior, like decision-making and speaking, and alterations in ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... 2014 Hospice & Palliative Care ... Celebration” gala, honoring three outstanding individuals for their ... to provide extraordinary and dignified comfort, care and ... or life-limiting illness. , The event was held ... and recognized William (Bill) J. McGuinness, Director of ...
(Date:9/30/2014)... SHELBY TOWNSHIP, Mich. (PRWEB) September 30, 2014 ... inventive chronic knee pain program of care ... patients. , His clinic—Johnson Chiropractic Neurology & ... focusing on the knee. It also addresses sources of ... as well as the “neurokinetic chain” from the brain ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... NEW YORK, May 29 With the May 26 launch ... inviting consumers to turn their basic daily movements into an ... Nintendo at: http://inr.mediaseed.tv/Nintendo_36542/ After counting ... Walking creates a series of charts and activities to ...
... 500 Company Signs New Leases Keeping Nearly 900 Jobs ... (NYSE: DVA ), a leading provider of ... disease (CKD), today announced it has completed negotiations to ... Avenue as well as at the Columbia Bank Center. ...
... IHSS ProgramSACRAMENTO, Calif., May 29 Gov. Schwarzenegger ... Supportive Services (IHSS) program that would all but ... more than 420,000 low-income elderly, blind and disabled ... individuals--nearly 90 percent of all IHSS consumers--would be ...
... LIONVILLE, Pa., May 29 West Pharmaceutical Services, Inc. ... E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, ... at the 2009 UBS Global Specialty Pharmaceuticals Conference at ... London, England. A copy of the corporate presentation document ...
... can ease symptoms, raise awareness of breathing patterns , , FRIDAY, ... tree pose a few times a week seems to improve ... In fact, participants in a recent trial studying the effects ... to cut back on some of their asthma medication, said ...
... Former director of the National Institutes of Health (NIH), Elias ... Trustees. Dr. Zerhouni, who directed the NIH from May 2002 ... board member on May 8th in Rochester. "We are very ... Chairman of the Mayo Clinic Board. "He brings a wealth ...
Cached Medicine News:Health News:VIDEO from Medialink and Nintendo: Nintendo Steps Up the Pace With Personal Trainer: Walking 2Health News:DaVita Extends Lease to Maintain Strong Business Presence in Tacoma 2Health News:Schwarzenegger Wants To Eliminate Home Care For 400,000 Elderly, Blind and Disabled Californians 2Health News:Yoga Helps Those With Asthma 2Health News:Former NIH Head Joins Mayo Clinic Trustees 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Enhanced features including aspiration holes ... in laparoscopic procedures requiring precise dissection ... and increased suction demands. ,Flexible ... retractable and nonretractable electrodes and multiple ...
Medicine Products: